Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Respiratory Medicine
|
April 8, 2026
Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease
Giulia Nalesso, Giulia Ferranti, Daniel-Costin Marinescu, et al.
Respiratory Medicine
|
December 24, 2023
Characteristics and risk factors of interstitial pneumonia with autoimmune features
Sana Vahidy, Jonathan Agyeman, Boyang Zheng, et al.
Respirology (Carlton, Vic.)
|
May 5, 2022
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
Cathryn T Lee, Mary E Strek, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society
|
September 7, 2023
Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung Disease
Ferhan Saleem, Christopher J Ryerson, Nandini Sarma, et al.
Thorax
|
August 31, 2021
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study
Sabina Anna Guler, Seo Am Hur, Michael K Stickland, et al.
The European Respiratory Journal
|
March 11, 2022
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry
Nathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva, et al.
ERJ Open Research
|
January 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysis
Jürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Annals of the American Thoracic Society
|
June 28, 2016
High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study
Christopher J Ryerson, Pat G Camp, Neil D Eves, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 18, 2025
Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis
Chad A Newton, Ashwatha Thenappan, Gabrielle Y Liu, et al.
Annals of the American Thoracic Society
|
June 1, 2026
Clinical and Radiologic Characteristics of Familial Pulmonary Fibrosis
Amanda Grant-Orser, Daniel-Costin Marinescu, Cameron J Hague, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Respiratory Medicine
|
April 8, 2026
Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease
Giulia Nalesso, Giulia Ferranti, Daniel-Costin Marinescu, et al.
Respiratory Medicine
|
December 24, 2023
Characteristics and risk factors of interstitial pneumonia with autoimmune features
Sana Vahidy, Jonathan Agyeman, Boyang Zheng, et al.
Respirology (Carlton, Vic.)
|
May 5, 2022
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
Cathryn T Lee, Mary E Strek, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society
|
September 7, 2023
Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung Disease
Ferhan Saleem, Christopher J Ryerson, Nandini Sarma, et al.
Thorax
|
August 31, 2021
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study
Sabina Anna Guler, Seo Am Hur, Michael K Stickland, et al.
The European Respiratory Journal
|
March 11, 2022
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry
Nathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva, et al.
ERJ Open Research
|
January 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysis
Jürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Annals of the American Thoracic Society
|
June 28, 2016
High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study
Christopher J Ryerson, Pat G Camp, Neil D Eves, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 18, 2025
Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis
Chad A Newton, Ashwatha Thenappan, Gabrielle Y Liu, et al.
Annals of the American Thoracic Society
|
June 1, 2026
Clinical and Radiologic Characteristics of Familial Pulmonary Fibrosis
Amanda Grant-Orser, Daniel-Costin Marinescu, Cameron J Hague, et al.
Page
of 7